Literature DB >> 36064866

The role of adenosine A1 receptor on immune cells.

Lingyu Zhong1, Qiao Peng2, Xun Zeng3.   

Abstract

BACKGROUND: Adenosine, acting as a regulator by mediating the activation of G protein-coupled adenosine receptor families (A1, A2A, A2B, and A3), plays an important role under physiological and pathological conditions. As the receptor with the highest affinity for adenosine, the role of adenosine A1 receptor (A1R)-mediated adenosine signaling pathway in the central nervous system has been well addressed. However, functions of A1R on immune cells are less summarized. Considering that some immune cells express multiple types of adenosine receptors with distinct effects and varied density, exogenous adenosine of different concentrations may induce divergent immune cell functions.
MATERIALS AND METHODS: The literatures about the expression of A1R and its regulation on immune cells and how it regulates the function of immune cells were searched on PubMed and Google Scholar.
CONCLUSION: In this review, we discussed the effects of A1R on immune cells, including monocytes, macrophages, neutrophils, dendritic cells, and microglia, and focused on the role of A1R in regulating immune cells in diseases, which may facilitate our understanding of the mechanisms by which adenosine affects immune cells through A1R.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Adenosine A1 receptor; Dendritic cells; Immune cells; Macrophage; Microglia; Neutrophils

Year:  2022        PMID: 36064866     DOI: 10.1007/s00011-022-01607-w

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   6.986


  80 in total

Review 1.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 2.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

Review 3.  Pharmacology of Adenosine Receptors: The State of the Art.

Authors:  Pier Andrea Borea; Stefania Gessi; Stefania Merighi; Fabrizio Vincenzi; Katia Varani
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.

Authors:  Ahmed Nadeem; Peter C M Obiefuna; Constance N Wilson; S Jamal Mustafa
Journal:  Eur J Pharmacol       Date:  2006-09-08       Impact factor: 4.432

Review 5.  Structure and function of adenosine receptor heteromers.

Authors:  Rafael Franco; Arnau Cordomí; Claudia Llinas Del Torrent; Alejandro Lillo; Joan Serrano-Marín; Gemma Navarro; Leonardo Pardo
Journal:  Cell Mol Life Sci       Date:  2021-02-12       Impact factor: 9.261

Review 6.  Pathological overproduction: the bad side of adenosine.

Authors:  Pier Andrea Borea; Stefania Gessi; Stefania Merighi; Fabrizio Vincenzi; Katia Varani
Journal:  Br J Pharmacol       Date:  2017-03-31       Impact factor: 8.739

Review 7.  Extracellular adenosine triphosphate and adenosine in cancer.

Authors:  J Stagg; M J Smyth
Journal:  Oncogene       Date:  2010-07-26       Impact factor: 9.867

Review 8.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

Review 9.  Adenosine A1 receptor antagonists and the kidney.

Authors:  Paul S Modlinger; William J Welch
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-09       Impact factor: 2.894

Review 10.  The adenosine pathway in immuno-oncology.

Authors:  Bertrand Allard; David Allard; Laurence Buisseret; John Stagg
Journal:  Nat Rev Clin Oncol       Date:  2020-06-08       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.